Robert H Bates

Title: The Innovations of Robert H Bates

Introduction

Robert H Bates is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mycobacterial infections. With a total of 2 patents, Bates has focused on developing innovative solutions to combat diseases such as tuberculosis.

Latest Patents

Bates' latest patents include a compound known as Sanfetrinem or a salt or ester thereof, which is designed for use in treating mycobacterial infections. This invention addresses the need for effective treatments for diseases resulting from mycobacterial infections, including tuberculosis. Another significant patent is for an antituberculosis agent, which relates to the use of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or its pharmaceutically acceptable salts. This invention also encompasses pharmaceutical formulations that include this compound, showcasing Bates' commitment to advancing medical therapies.

Career Highlights

Robert H Bates is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a focus on developing new therapeutic agents that can significantly improve patient outcomes.

Collaborations

Bates has collaborated with notable colleagues such as David Barros Aguirre and Lluis Ballell Pages. These partnerships have likely contributed to the success of his inventions and the advancement of research in his field.

Conclusion

Robert H Bates exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his dedication to improving treatments for serious infections. His work continues to impact the medical community positively.